key: cord-0721774-ifl2m2t3
authors: Awulachew, Ephrem; Diriba, Kuma; Anja, Asrat; Getu, Eyob; Belayneh, Firehiwot
title: Computed Tomography (CT) Imaging Features of Patients with COVID-19: Systematic Review and Meta-Analysis
date: 2020-07-23
journal: Radiol Res Pract
DOI: 10.1155/2020/1023506
sha: dbcdbebf16e6276999c6ee8913cc9d77db85ac77
doc_id: 721774
cord_uid: ifl2m2t3

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious disease, and its first outbreak was reported in Wuhan, China. A coronavirus disease (COVID-19) causes severe respiratory distress (ARDS). Due to the primary involvement of the respiratory system, chest CT is strongly recommended in suspected COVID-19 cases, for both initial evaluation and follow-up. OBJECTIVE: The aim of this review was to systematically analyze the existing literature on CT imaging features of patients with COVID-19 pneumonia. METHODS: A systematic search was conducted on PubMed, Embase, Cochrane Library, Open Access Journals (OAJ), and Google Scholar databases until April 15, 2020. All articles with a report of CT findings in COVID-19 patients published in English from the onset of COVID-19 outbreak to April 20, 2020, were included in the study. RESULT: From a total of 5041 COVID-19-infected patients, about 98% (4940/5041) had abnormalities in chest CT, while about 2% have normal chest CT findings. Among COVID-19 patients with abnormal chest CT findings, 80% (3952/4940) had bilateral lung involvement. Ground-glass opacity (GGO) and mixed GGO with consolidation were observed in 2482 (65%) and 768 (18%) patients, respectively. Consolidations were detected in 1259 (22%) patients with COVID-19 pneumonia. CT images also showed interlobular septal thickening in about 691 (27%) patients. CONCLUSION: Frequent involvement of bilateral lung infections, ground-glass opacities, consolidation, crazy paving pattern, air bronchogram signs, and intralobular septal thickening were common CT imaging features of patients with COVID-19 pneumonia.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious disease, and its first outbreak was reported in Wuhan, China [1] . On January 30, 2020, the World Health Organization (WHO) declared it a pandemic disease [2] . Currently, the disease has been reported in more than 212 countries worldwide [3] . As of May 01, a total of 3,325,620 cases and 234,496 deaths due to COVID-19 were reported worldwide [4] . e most common diagnostic tool for coronavirus disease 2019 infection is realtime polymerase chain reaction (RT-PCR), which is regarded as the reference standard [5, 6] .

COVID-19 causes severe respiratory distress (ARDS). Due to the primary involvement of the respiratory system, chest computed tomography (CT) is strongly recommended in suspected COVID-19 cases, for both initial evaluation and follow-up [7] . Recent studies addressed the importance of chest CT examination in COVID-19 patients with falsenegative RT-PCR results [8] and reported the CT sensitivity as 98% [9] . Additionally, CT examinations also have great significance in monitoring disease progression and evaluating therapeutic efficacy. e SARS-CoV-2 has four major structural proteins: the spike surface glycoprotein, small envelope protein, matrix protein, and nucleocapsid protein [10] . e spike protein binds to host receptors via the receptor-binding domains (RBDs) of angiotensin-converting enzyme-2 (ACE2) [11] . e ACE2 protein has been identified in various human organs, including the respiratory system, GI tract, lymph nodes, thymus, bone marrow, spleen, liver, kidney, and brain. SARS-CoV-2 was reported to utilize angiotensin-converting enzyme-2 (ACE2) as the cell receptor in humans [12] , firstly causing pulmonary interstitial damage and subsequently with parenchymal changes. Reportedly, chest CT images could manifest different imaging features or patterns in COVID-19 patients with different time course and disease severity [13, 14] .

Studies suggest that routine chest CT is a useful tool in the early diagnosis of COVID-19 infection, especially in settings of limited availability of reverse-transcriptase polymerase chain reaction (RT-PCR [15] . Imaging is critical in assessing severity and disease progression in COVID-19 infection. Radiologists should be aware of the features and patterns of imaging manifestations of the novel COVID-19 infection. A variety of imaging features have been described in similar coronavirus-associated syndromes. Due to an alarming spread of COVID-19 outbreak throughout the world, a comprehensive understanding of the importance of evaluating chest CT imaging findings is essential for effective patient management and treatment. Individual literature published is required to be summarized. us, a comprehensive systematic review has to be performed. erefore, this study systematically reviewed CT imaging features of patients with COVID-19 pneumonia.

A systematic search was conducted on PubMed, Embase, Cochrane Library, Open Access Journals (OAJ), and Google Scholar databases until April 15, 2020. Keywords used to search eligible studies were "severe acute respiratory syndrome 2," "SARS CoV 2," "2019-nCoV," "COVID-19," "computed tomography," "CT," and "radiology." All identified keywords and mesh terms were combined using the "OR" operator and "AND" operator for searching literatures. We simultaneously searched the reference lists of all recovered articles for potentially eligible studies.

All articles with a report of CT findings in COVID-19 patients published in English from the onset of COVID-19 outbreak to April 20, 2020, were included in the study. Case studies and case series reported on chest CT imaging findings of patients with COVID-19 were included with caution. Studies pertaining to other coronavirus-related illnesses were excluded.

Studies selected for inclusion were assessed for methodological quality by two teams of independent reviewers using the standard critical appraisal instruments of the Joanna Briggs Institute Meta-Analysis of Statistics Assessment for the Review Instrument (JBI-MAStARI) [16] . Disagreements were resolved by consensus.

Data were extracted by two teams of the investigators using a standardized data extraction form. In addition, eligible case studies and case series studies were extracted carefully. en the extracted data were merged for systematic analysis. e main outcomes extracted from each study were study design, country, patient demographics, and chest CT findings. Additional findings extracted were the patient's clinical characteristics. Disagreements were discussed with other reviewers and subsequently resolved via consensus.

Analysis and Data Synthesis. Systematic reviews and meta-analyses were carried out using R software version 3.6.1 with user-contributed commands for meta-analyses: metaprop, metan, metainf, metabias, and metareg. e effect sizes and SEs of the studies were pooled using a randomeffects model to calculate the pooled estimates of CT findings among COVID-19 patients. A meta-analysis was also planned to assess the association of various imaging findings with demographic data.

Evidence for statistical heterogeneity of the results was assessed using the Cochrane Q x2 test and I2 statistic. A significance level of P < 0.10 and I2 >50% was interpreted as evidence of heterogeneity [17] . A potential source of heterogeneity was investigated by subgroup analysis and meta-regression analysis [18] . Where statistical pooling was not possible, the findings were presented in a narrative form including tables and figures to aid in data presentation where appropriate.

Sensitivity analyses were conducted to weigh up the relative influence of each individual study on the pooled effect size using a user-written function, metainf. e presence of publication bias was assessed informally by visual inspection of funnel plots [19] .

Following the initial search, 241 studies were identified from the electronic databases ( Figure 1 ). After the removal of 67 duplicates, 17 noneligible studies, and six studies with unclear population, 78 studies were retrieved for full-text review. Of this, 18 studies were of poor quality that did not meet the eligibility criteria. Following methodological quality assessment, 60 articles were included in the meta-analysis. In the included studies, a total of 5041 patients with COVID-19 were assessed for CT imaging features. All papers were published in English.

In this review, 60 papers were eligible and a total of 5041 patients had CT imaging findings [8, [12] [13] [14] . From a total of 5401 participants, about half of them were male 2710 (50.2%), while 2693 (49.8%) were female. e mean age of the participants was 49 years with a standard deviation of 11.6 years. 

Patients. We performed meta-analyses of primary outcome data and secondary outcomes with available data. From a total of 5041 COVID-19-infected patients, about 98% (4940/ 5041) had abnormalities in chest CT, while about 2% had normal chest CT findings ( Figure 2 ). Among COVID-19 patients with abnormal chest CT findings, 80% (3952/4940) had bilateral lung involvement. About 20% (641/3206) patients had exclusively unilateral lung involvement. When a single lobe was involved, the right lung was most often affected (62%) and 38% of them had only left lung involvement. In the right lung, the lower lobe was frequently involved (74% (784)), while the middle lobe was less frequent (38% (326)). In the left lung, the upper lobe was frequently involved (74% (731)).

Regarding the patterns of lung lesions in patients with COVID-19, ground-glass opacity (GGO) and mixed GGO with consolidations were observed in 2482 (65%) and 768 (18%) patients, respectively. Consolidation, which is defined as denser opacities and blurred margins of pulmonary blood vessels and bronchial tubes, was detected in 1259 (22%) patients with COVID-19 pneumonia. CT images also showed interlobular septal thickening in about 691 (27%) patients. CT showed that 11 (21.6%) patients had discrete pulmonary nodules. Crazy paving patterns of lesions were observed in 575 Figure 1 : Flow chart of the search and study inclusion. [40, 43, 44, 50, 52, 57, [64] [65] [66] . Our findings demonstrated pure ground-glass opacity in early disease, followed by the development of crazy paving, and finally increasing consolidation latter in the disease course. GGO density increased and transformed into consolidation; consolidation edges were flat or contracted; and fibrous cord shadow appeared. GGO with consolidation was higher in the advanced stage than in the early stage of the disease (OR 3.2, 95% CI: 2.2-4.7, P � 0.013). A crazy paving pattern and a reverse halo sign were all rare in the early sign, but were present in the late stage of the disease. In terms of distribution of disease, bilateral involvements were prominent in the later stage than in the early stage (P < 0.001). According to the report of two included studies, pure GGO was the common imaging feature of mild and moderate stages of the disease course, while consolidation and GGO with consolidation increased by 64% and 79% in the critical stage of the disease, respectively [57, 58] .

Subgroup analysis was conducted to justify the cause of heterogeneity. Subgroup analysis of the included studies showed that the possible cause of heterogeneity was sample size (P value < 0.01).

Funnel plots did not suggest a publication bias for the majority of the parameters. We demonstrated no publication bias (P value � 0.1947).

In this review, we have demonstrated that the main signs and symptoms of hospital admission of patients with COVID-19 pneumonia were fever, dry cough, fatigue, pharyngeal pain, and respiratory distress. About 24% of the patients had reduced total leukocyte count and 43% had reduced lymphocyte count. Although the laboratory findings are not specific for viral pneumonia, leukopenia and lymphocytopenia may be helpful to distinguish COVID-19 from common bacterial infections. e majority of the patients had increased C-reactive protein.

In this study, common CT imaging features in patients with COVID-19 pneumonia included bilateral involvement, ground-glass opacities, consolidation, crazy paving pattern, air bronchogram signs, and intralobular septal thickening. At a later stage of the disease, mixed GGO with consolidation was the more frequent finding. Pulmonary consolidation was mainly found in the severe and progressive late stages of the disease, which can coexist with ground-glass and fibrotic changes. e pathological basis of these changes could be due to inflammatory cell infiltration and interstitial thickening, cell exudation, and hyaline membrane formation.

In the present study, the increased frequency of GGO, consolidation, bilateral disease, intralobular septal thickening, a crazy paving pattern of the lesion, and appearance of reverse halo sign lesions over more than one lobe of the lung could represent the pathophysiology of the disease process as it organizes and it could also probably explain chest CT hallmark of COVID-19 infection. CT imaging findings can be correlated with the severity of the disease and disease progression after efforts of treatment. e majority of the patients (76%) had multilobar involvement, and lesions were more frequent in the right lung. Pleural effusion, lymphadenopathy, and pulmonary nodules were less common imaging findings in these patients. About 2% of the patients had normal initial CT findings. When a single lobe was involved, the right lung was most often affected and more than half of the patients with COVID-19 had multiple lobe infections. In the right lung, the lower lobe is frequently involved while the middle lobe was less frequent. In the left lung, the upper lobe was frequently involved. is might indicate the virus tends to disseminate all over all lobes of both lungs as the disease progress. Chest CT imaging features may avoid repeated laboratory testing and may be helpful in a resource-limited country.

According to the present study, chest CT imaging showed similar characteristics in the majority of patients, including predominantly bilateral and multilobe involvement. e pattern of ground-glass and consolidative pulmonary opacities, often with a bilateral lung distribution, is somewhat similar to that described in earlier coronavirus outbreaks such as SARS and MERS, which was known to cause ground-glass opacities that may coalesce into dense consolidative lesions [73, 74] .

According to the report of 9 included studies, 43% (95 CI: 26%-61%) patients have improved follow-up chest CT findings, while 30% (95 CI: 18%-46%) have advanced chest CT findings. Our findings demonstrated pure ground-glass opacity in early disease, followed by the development of crazy paving and finally increasing consolidation latter in the disease course. According to the report of two included studies, pure GGO was the common imaging feature of mild and moderate stages of the disease course, while consolidation and GGO with consolidation increased by 64% and 79% in the critical stage of the disease, respectively.

is systematic review and meta-analysis came up with CT imaging features of patients with COVID-19; we acknowledge a few limitations of the present systematic review and meta-analysis, which may affect the results. First of all, two relevant studies which were identified through our literature search were excluded due to unavailability for fulltext review. e other limitation of the present study was that it was limited to articles published in English.

e present study showed that common CT imaging features of COVID-19 pneumonia included frequent involvement of bilateral lung infections, ground-glass opacities, consolidation, crazy paving pattern, air bronchogram signs, and intralobular septal thickening. Bilateral involvement was common while single lobe involvement was rare. is sign of CT imaging might be an important tool for diagnosis and monitoring disease progression in patients with COVID-19 infection.

Angiotensin-converting enzyme-2 ARDS:

Acute respiratory distress CT:

Computed tomography imaging COVID-19: Coronavirus disease 2019 GGO:

Ground-glass opacity 2019-nCoV: Novel coronavirus SAR CoV 2: Severe acute respiratory syndrome coronavirus 2.

e authors declare that they have no conflicts of interest.

E. A, K. D, A. A, E.G, and F. B designed the study, extracted, critically reviewed, and analyzed the data, and wrote the first draft of the manuscript and approved the manuscript.

Figure 2: Magnitude of abnormal chest CT finding of patients with COVID-19. References

A novel coronavirus from patients with pneumonia in China

COVID-19) Situation Report-39, World Health Organization

Updated understanding of the outbreak of 2019 novel coronavirus

World Health Organization, Update on the Situation Regarding the New Coronavirus, World Health Organization

COVID-19): Epidemiology, Virology, Clinical Features, Diagnosis, and Prevention, Practice changing updates

World Health Organization, Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases, World Health Organization

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China

Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Guidelines for Systematic Reviews of Health Promotion and Public Health Interventions: Version 2

Explaining heterogeneity in meta-analysis: a comparison of methods

e comparison of percentages in matched samples

Bias in meta-analysis detected by a simple, graphical test

Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Correlation of Chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Differences in clinical and imaging presentation of pediatric patients with COVID-19 in comparison with adults

Proposal of a lowdose, long-pitch, dual-source chest CT protocol on thirdgeneration dual-source CT using a tin filter for spectral shaping at 100 kVp for coronavirus disease 2019 (COVID-19) patients: a feasibility study

Lung base findings of coronavirus disease (COVID-19) on abdominal CT in patients with predominant gastrointestinal symptoms

Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single

Imaging features of coronavirus disease 2019 (COVID-19): evaluation on thinsection CT

Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT?

18 F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak

2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation

2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features

Emerging 2019 novel coronavirus (2019-nCoV) pneumonia

Pulmonary high-resolution computed tomography (HRCT) findings of patients with early-stage coronavirus disease 2019 (COVID-19) in Hangzhou, China

Frequency and distribution of chest radiographic findings in COVID-19 positive patients

Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19

Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study

Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features

Computed tomographic imaging of 3 patients with coronavirus disease 2019 pneumonia with negative virus real-time reverse-transcription polymerase chain reaction test

Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area

CT manifestations of coronavirus disease-2019: a retrospective analysis of 73 cases by disease severity

CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)

Analysis of clinical characteristics of 30 new coronavirus pneumonia in medical staff

High-resolution computed tomography manifestations of 5 pediatric patients with 2019 novel coronavirus

CT imaging features of 2019 novel coronavirus (2019-nCoV)

Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China

CT imaging analysis of lungs in 33 patients with new coronavirus infection

Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia

CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China

Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea

Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer

Ultra high resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia

Computed tomography manifestations of 5 cases of the novel coronavirus disease 2019 (COVID-19) pneumonia from patients outside Wuhan

A comparative study of chest computed tomography features in young and older adults with corona virus disease (COVID-19)

Clinical analysis of 31 cases of 2019 new coronavirus infection in children from six provinces (autonomous regions) in Northern China

CT findings of coronavirus disease (COVID-19) severe pneumonia

Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults

Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study

CT imaging and differential diagnosis of COVID-19

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city

CT distribution characteristics and signs of 130 cases of novel coronavirus pneumonia

Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital

A diagnostic model for coronavirus disease 2019 (COVID-19) based on radiological semantic and clinical features: a multi-center study

Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings

CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China

Novel coronavirus pneumonia (COVID-19) progression course in 17 discharged patients: comparison of clinical and thin-Section CT features during recovery

Dynamic chest CT evaluation in three cases of 2019 novel coronavirus pneumonia

Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2

Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study

Case report on early diagnosis of COVID-19

Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients

e clinical pathology of severe acute respiratory syndrome (SARS): a report from China

Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the United Arab Emirates